The involvement of K+ATP channels in the regulation of pulmonary and systemic vascular tone in the pig

Biomedical Research (India)

Volumn 7, Issue 2, 1996, Pages 197-204

  Albertini, M ^a   Dimori, M ^a   Clement, M G ^a   Aguggini, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cromakalim; Glibenclamide; K+ATP channels; Pulmonary vascular tone; Systemic vascular tone

Indexed keywords

CROMAKALIM; GLIBENCLAMIDE; INDOMETACIN; INDOMETACIN MEGLUMINE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PULMONARY ARTERY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0029744962     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 2 and nitric oxide involvement in the regulation of systemic and pulmonary basal vascular tone on the pig. Prost Leuk and Ess FA, accepted Aug 21-1995. 1996.
2. Boczkowski J, Vicaut E, Danialou G. et al. Role of nitric oxide and prostaglandins in the regulation of diaphragmatic arteriolar tone in the rat. J App. Physiol 1994; 77: 590-596.
3. Busse R Luckhoff A, Pohl U. Role of membrane potential in the synthesis and release of EDRF. In: Endothelial regulation of vascular tone. 1992; US Ryan and GM Rubanyi (eds) Marcel Dekker. Inc New York, 105-120.
4. Buckingham RE, Clapham JC Hamilton TC et al. BRL 34915 a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 1986; 8:798-804.
5. Cavero I Mondot S and Mestre M. Vasorelaxant effect of cromakalim in rats are mediated by glibenclamide-sensitive. J Pharmacol Exper Ther: 1261-1268.
6. Chand N Altura BM. Acetylcholine and bradykinin relax intrapilmonary arteries by acting on endothelial cells, role in lung vascular disease. Science 1981; 213: 1376-1379.
7. + channel pulmonary vaosdilation in fetal lambs: role of endothelium-derived nitric oxide. J App Physiol 1992; 73(1): 188-194.
8. + channel. Pflug Arch 1989; 414:S80-S87.
9. Hicks PE, Martin D, Dumez D et al. Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs. Pflug Arch 1989, 141; S192-S193.
10. Lippton HE, Cohen Ga, McMurtry IF et al. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J App Physiol 1991; 70(2): 947-952.
11. Lückhoff A., Busse R. Activators of potassium channels enhances calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Scluniedebergs Arch Pharmacol 1990; 342:94-99.
12. ATP channels Am J Physiol 1991; 260: H957-H966.
13. Nelson MT, Patlak BJ, Worley JF et al. Calcium channels, potassium chaimels, and voltage dependence of arterial smooth muscle. Am J Physiol 1990; 259(28): C3-C18.
14. Nelson MT, Quayle MJ Physiological roles and properties of potassium chaimels in arterial smooth muscle. Am J Physiol 1995, 268: C799-C822.
15. Palmer RMJ, Ferrige AG, Moncada SA Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
16. + channel openers, diazoxide and cromakalim, and their inhibition of glibenclamide. J Pharmacol Exp Ther 1989; 250: 261-271.
17. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci 1990; 47: 1693-1705.
18. Vandenberg MJ, Woodward SA, Hassein M et al. Potassium channel activators lower blood pressure: an initial study of BRL 34915 in patients. J Hypert 1986, 4: S166-S167.
19. Vanelli G, Hussain SNA, Aguggini G. Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endo-toxin-induced hypotension in pig. Exp Physiol 1995; 80: 167-170.